CMND
Clearmind Medicine Inc. Common Shares
NASDAQ: CMND · HEALTHCARE · BIOTECHNOLOGY
$0.70
-5.61% today
Updated 2026-04-29
Market cap
$1.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-24.12
Dividend yield
—
52W range
$1 – $52
Volume
5.8M
Clearmind Medicine Inc. Common Shares (CMND) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-119.70%
ROA
-55.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $0.00 | $-33233.00 | — | — | — |
| 2015 | $0.00 | $-46857.00 | — | — | — |
| 2016 | $0.00 | $-24215.00 | — | — | — |
| 2017 | — | $-6529.00 | — | — | — |
| 2018 | — | $-194535.00 | — | — | — |
| 2019 | $0.00 | $-105283.00 | — | — | — |
| 2020 | $0.00 | $-233220.00 | — | — | — |
| 2021 | $0.00 | $-3.66M | — | — | — |
| 2022 | $0.00 | $-9.93M | — | — | — |
| 2023 | $0.00 | $-11.85M | — | — | — |
| 2024 | $0.00 | $-7.31M | — | — | — |
| 2025 | $0.00 | $-3.86M | — | — | — |